Stock Price
97.96
Daily Change
0.70 0.72%
Monthly
-28.78%
Yearly
-59.49%
Q2 Forecast
96.11

CSL reported $5.07 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Arca Biopharma USD -0.54 0.14 Dec/2025
aTyr Pharma USD 0.53 0.8 Dec/2025
Bio Path USD -0.07 0.48 Sep/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
CSL USD 5.07 3 Dec/2025
Curis USD 1.23 3.26 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024